A technology has been developed that can screen for lung cancer at an early stage using exhaled breath. This technology demonstrated 95% accuracy in clinical settings. It is expected to contribute to ...

All study participants simultaneously underwent NGS using three sample types: (1) BWF, (2) plasma, and (3) tumor tissue collected during bronchoscopy. The full patient set (FPS) included all enrolled ...

Lung cancer symptoms are often non-specific, leading to late detection and misattribution to less severe conditions. The GO2 for Lung Cancer provides resources, policy advocacy, and access to clinical ...

For most of the last century, a diagnosis of lung cancer was often regarded as a death sentence. As an oncologist, I have witnessed dramatic changes over the past two decades, particularly in the last ...

bioAffinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung ...

A Chinese research team has developed the world's first blood-based diagnostic kit that can tell whether lung nodules are benign or cancerous, including very small nodules that are often difficult to ...

World Lung Cancer Day is observed annually on August 1 across the globe. The day was first established in 2012, through the efforts of the Forum of International Respiratory Societies (FIRS) and the ...

Lung cancer remains the leading cause of cancer-related mortality worldwide despite advances in early detection and treatment. Furthermore, its epidemiology has undergone a profound transformation, ...